Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..10 of 24 - per page Next page
Order by
APR is a Swiss based R&D company offering innovative patent protected products for out-licensing as well as integrated and centrally managed R&D services on a contract basis. More
The worldwide leader in market research publications, advisory services and consulting More
Leksir develops and markets original pharmaceuticals and brand generics in four therapeutic areas. More
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
Foam products for Dermatology, Gynecology, Cosmetics, Wound Healing and more More
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
Replizyme is a service and contract research company specialising in viral enzyme targets and predictive toxicity services to pharmaceutical and biotechnology markets More
Anadis Limited is a biopharmaceutical research and development company specialising in innovative products containing antibodies and bioactive factors. More
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Displaying 1..10 of 24 - per page Next page
Order by
Partnering consultation free of charge
Pharma Business Strategies for Biomarkers
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us